Skip to content
Markets News
Earnings1 min read

BASF Raises 2026 Earnings Target After Stronger Third Quarter

Makkler Newsroom
October 28, 2026 · Based on reporting by finanzen.net

The German chemicals group lifted its adjusted EBITDA range, while analysts flagged a softer fourth-quarter outlook and BASF discussed Evonik.

Key takeaways

  • BASF raised its 2026 adjusted EBITDA target to €7.4 billion-€7.8 billion.
  • Third-quarter operating profit was €1.64 billion, above analyst expectations.
  • BASF’s latest reported offer for Evonik was €24 per share, according to people familiar with the transaction.

BASF raised its 2026 adjusted EBITDA target after third-quarter operating profit beat analyst expectations. The company now expects adjusted EBITDA of €7.4 billion to €7.8 billion, up from its previous range of €6.9 billion to €7.7 billion.

Operating profit reached €1.64 billion in the quarter, compared with €1.43 billion a year earlier. Revenue rose 14.2% to €16.36 billion, supported by higher prices and sales volumes. BASF said Chemicals and Nutrition & Care made the strongest contributions.

Net profit attributable to shareholders fell nearly 10% to €155 million, partly because of restructuring costs, including employee severance payments. BASF kept its full-year free cash flow forecast at €1.5 billion to €2.3 billion.

The shares traded at €52.57, up 0.86% from the previous close, as of 16:09 UTC on Wednesday. Jefferies and JPMorgan analysts said BASF’s outlook pointed to fourth-quarter operating profit below current market expectations.

BASF weighs Evonik bid

BASF chief executive Markus Kamieth again said a purchase of Evonik could make sense, but stressed the company would not pay an excessive price. According to people familiar with the transaction cited by dpa-AFX and dpa, BASF recently raised its offer to about €24 per share, or more than €11 billion in total.

BASF has not commented on the status of talks, citing confidentiality. The companies and Evonik’s largest shareholder, the RAG Foundation, disclosed in late September that there was a takeover offer.

Topics
BASEVKEvonik
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.